TY - JOUR
T1 - Evaluating the association of allergies with multiple sclerosis susceptibility risk and disease activity in a pediatric population
AU - US Network of Pediatric MS Centers
AU - Bourne, Theresa
AU - Waltz, Michael
AU - Casper, T. C.
AU - Kavak, K.
AU - Aaen, G.
AU - Belman, A.
AU - Benson, L.
AU - Candee, M.
AU - Chitnis, T.
AU - Graves, J.
AU - Greenberg, B.
AU - Gorman, M.
AU - Harris, Y.
AU - Krupp, L.
AU - Lotze, T.
AU - Mar, S.
AU - Ness, J.
AU - Olsen, C.
AU - Roalstad, S.
AU - Rodriguez, M.
AU - Rose, J.
AU - Rubin, J.
AU - Schreiner, T.
AU - Tillema, J. M.
AU - Kahn, I.
AU - Waldman, A.
AU - Barcellos, L.
AU - Waubant, E.
AU - Weinstock-Guttman, B.
N1 - Funding Information:
We thank our patients and their families for contributing to this study, as well as our study coordinators for enrolling participants. This work was supported by the National Multiple Sclerosis Society (NMSS) and the National Institute of Neurological Disorders and Stroke (NINDS) through the following grants: HC0165 and 1R01NS071463.
Publisher Copyright:
© 2017 Elsevier B.V.
PY - 2017/4/15
Y1 - 2017/4/15
N2 - Background Multiple sclerosis (MS) and allergies are both considered to be related to imbalanced Th1 and Th2 immune responses. Previous studies evaluating the relationship between MS and allergies provide conflicting results. Objective To assess allergies and asthma as risk factors for MS and as predictors of MS relapses in a pediatric cohort. Methods The environment and genetic risk factors for pediatric MS study is a national case-control project with 16 participating US sites. An environmental questionnaire is used that includes history of allergies in the first five years of life. Case-control data are entered in the pediatric MS Network database and cases at 12 of the 16 sites enter relapse data prospectively. Annualized relapse rate was calculated for patients with follow-up and adjusted for age at disease onset, gender, race, ethnicity, and use of disease-modifying therapy (DMT). Results We included 271 cases (mean age at disease onset of 15.7 years and 62% female) and 418 controls. Relapse data were available for 193 cases. There was no difference in prevalence of allergies or asthma between cases and controls. Patients with food allergies had fewer relapses compared to patients without food allergies (0.14 vs 0.48, p = 0.01). Conclusions While allergies and asthma are not associated with pediatric MS, cases with food allergies have fewer relapses compared to those without food allergies.
AB - Background Multiple sclerosis (MS) and allergies are both considered to be related to imbalanced Th1 and Th2 immune responses. Previous studies evaluating the relationship between MS and allergies provide conflicting results. Objective To assess allergies and asthma as risk factors for MS and as predictors of MS relapses in a pediatric cohort. Methods The environment and genetic risk factors for pediatric MS study is a national case-control project with 16 participating US sites. An environmental questionnaire is used that includes history of allergies in the first five years of life. Case-control data are entered in the pediatric MS Network database and cases at 12 of the 16 sites enter relapse data prospectively. Annualized relapse rate was calculated for patients with follow-up and adjusted for age at disease onset, gender, race, ethnicity, and use of disease-modifying therapy (DMT). Results We included 271 cases (mean age at disease onset of 15.7 years and 62% female) and 418 controls. Relapse data were available for 193 cases. There was no difference in prevalence of allergies or asthma between cases and controls. Patients with food allergies had fewer relapses compared to patients without food allergies (0.14 vs 0.48, p = 0.01). Conclusions While allergies and asthma are not associated with pediatric MS, cases with food allergies have fewer relapses compared to those without food allergies.
KW - Allergies
KW - Multiple sclerosis
KW - Pediatric
UR - http://www.scopus.com/inward/record.url?scp=85013646295&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85013646295&partnerID=8YFLogxK
U2 - 10.1016/j.jns.2017.02.041
DO - 10.1016/j.jns.2017.02.041
M3 - Article
C2 - 28320170
AN - SCOPUS:85013646295
SN - 0022-510X
VL - 375
SP - 371
EP - 375
JO - Journal of the Neurological Sciences
JF - Journal of the Neurological Sciences
ER -